Core Viewpoint - WuXi AppTec (603259.SH/2359.HK) announced its first interim dividend plan, distributing a total cash dividend of 1.03 billion yuan, reflecting strong financial performance in the first half of the year [1] Financial Performance - For the first half of the year, WuXi AppTec achieved a revenue of 20.799 billion yuan, a year-on-year increase of 20.6% [1] - The net profit attributable to shareholders reached 8.287 billion yuan, up 95.5% year-on-year [1] - In Q2, the company reported revenue of 11.145 billion yuan, marking the first time it surpassed 10 billion yuan in a single quarter [1] Dividend Distribution - The total cash dividends distributed to investors this year, including annual, special, and interim dividends, amounted to 4.88 billion yuan [1] - The total cash dividends and share buybacks reached 6.88 billion yuan, accounting for over 70% of the company's projected net profit for 2024 [1] Order Backlog and Revenue Sources - As of June 2025, the company had a backlog of orders amounting to 56.69 billion yuan, a year-on-year growth of 37.2% [2] - Revenue from U.S. clients was 14.03 billion yuan, up 38.4% year-on-year, while revenue from European clients was 2.33 billion yuan, a 9.2% increase [2] Business Model and Growth Drivers - The growth is attributed to the focus on an "integrated, end-to-end" CRDMO business model, enhancing operational efficiency and expanding capabilities [4] - The sale of partial equity in the joint venture WuXi XDC Cayman Inc. is expected to yield an investment income of approximately 3.21 billion yuan [4] Future Projections - The company expects revenue growth for its ongoing business to return to double digits, with the growth rate adjusted from 10%-15% to 13%-17% [4] - Overall revenue projections for the year have been revised from 41.5-43 billion yuan to 42.5-43.5 billion yuan [4] Accounts Receivable Trends - Accounts receivable increased from 3.665 billion yuan in 2020 to 7.918 billion yuan in Q1 2025, with the proportion of accounts receivable to revenue rising from 15.18% in 2022 to 19.59% in 2023 [5]

Core Insights - WuXi AppTec has implemented its first interim dividend plan, distributing a total of RMB1.03 billion in cash dividends [1] - The company has distributed a total of RMB4.88 billion in cash dividends to investors this year, which includes annual, special, and interim dividends [2] - The total cash dividends, along with share repurchases and cancellations, amount to RMB6.88 billion, representing over 70% of the net profit attributable to the owners of the company in 2024 [2] Company Overview - WuXi AppTec is a global provider of R&D and manufacturing services for the pharmaceutical and life sciences industries, operating across Asia, Europe, and North America [4] - The company offers integrated, end-to-end services through its CRDMO (Contract Research, Development, and Manufacturing Organization) platform, collaborating with nearly 6,000 partners in over 30 countries [4]

Core Points - The company announced a cash dividend of RMB 0.35000 per share (including tax) for the first half of 2025, totaling RMB 1,033,027,357.60 (including tax) to be distributed among A-share shareholders [2][4] - The distribution plan was approved by the board of directors on July 28, 2025, following authorization from the annual general meeting held on April 29, 2025 [2][3] Distribution Plan - The dividend will be distributed to all A-share shareholders registered with China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the registration date [3] - The total number of shares for the dividend calculation is 2,951,506,736 shares, with A-shares receiving a total of RMB 865,648,086.10 (including tax) [4] Taxation Details - For individual A-share shareholders, the cash dividend will not be subject to withholding personal income tax at the time of distribution. The actual amount received will be RMB 0.35000 per share [6] - Qualified Foreign Institutional Investors (QFII) will have a 10% corporate income tax withheld, resulting in an actual distribution of RMB 0.31500 per share [7] - Hong Kong investors through the Stock Connect will also face a 10% withholding tax, leading to an effective dividend of RMB 0.31500 per share [8] - Other institutional investors and corporate shareholders will receive the full amount of RMB 0.35000 per share without tax withholding [9]

Group 1 - The core point of the article is that WuXi AppTec announced its cash dividend distribution plan for the first half of 2025, which is set at 0.35 yuan per share (tax included) [1] - The record date for the dividend distribution is September 25, 2025, and both the ex-dividend date and the cash dividend payment date are September 26, 2025 [1]

（於中華人民共和國註冊成立的股份有限公司） （股份代號：2359） 海外監管公告 本海外監管公告乃由本公司根據香港聯合交易所有限公司證券上市規則第 13.10B條作出。 茲載列本公司在上海證券交易所網站刊登的以下資料中文全文，僅供參閱。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或 因依賴該等內容而引致之任何損失承擔任何責任。 WUXI APPTEC CO., LTD. * 無錫藥明康德新藥開發股份有限公司 承董事會命 無錫藥明康德新藥開發股份有限公司 董事長 李革博士 香港，2025年9月19日 截至本公告日期，本公司董事會包括執行董事李革博士、陳民章博士、楊青博士及張朝暉先生； 非執行董事童小幪先生及吳亦兵博士；以及獨立非執行董事盧韶華女士、俞衛博士、張新博士、 詹智玲女士及冷雪松先生。 * 僅供識別 证券代码：603259 证券简称：药明康德 公告编号：临 2025-063 无锡药明康德新药开发股份有限公司 2025年半年度A 股权益分派实施公告 本公司董事会及全体董事保证本公告内容不存 ...

证券代码：603259 证券简称：药明康德 公告编号：临 2025-063 A 股每股现金红利0.35000元（含税） 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/9/25 | － | 2025/9/26 | 2025/9/26 | 差异化分红送转： 否 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经无锡药明康德新药开发股份有限公司（以下简称"本公 司"） 2025 年 4 月 29 日的2024年年度股东大会授权董事会在符合利润分配的条件 下制定具体的中期分红方案，并经 2025 年 7 月 28 日召开的第三届董事会第二十 二次会议审议通过。 无锡药明康德新药开发股份有限公司 2025年半年度A 股权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放 ...

无锡药明康德新药开发股份有限公司发布2025年半年度A股权益分派实施公告。本次利润分配方案经 2024年年度股东大会授权及第三届董事会第二十二次会议审议通过。以总股本2,951,506,736股为基数， 每股派发现金红利0.35元（含税），A股共派发现金红利865,648,086.10元（含税）。股权登记日为2025 年9月25日，除权（息）日和现金红利发放日为9月26日。不同类型股东扣税政策有别，如自然人股东和 证券投资基金暂不扣缴，QFII股东和沪股通投资者按10%税率代扣。如有疑问可联系董事会办公室，电 话021 - 20663091。 ...

Company Overview - WuXi AppTec, established on December 1, 2000, is located in Shanghai and Hong Kong, and was listed on May 8, 2018. The company provides a comprehensive platform for the discovery, development, and manufacturing of small molecule chemical drugs, serving global pharmaceutical companies [1][2]. Financial Performance - For the first half of 2025, WuXi AppTec achieved a revenue of 20.799 billion yuan, representing a year-on-year growth of 20.64%. The net profit attributable to shareholders was 8.561 billion yuan, showing a significant increase of 101.92% year-on-year [2]. - The company has distributed a total of 13.027 billion yuan in dividends since its A-share listing, with 9.373 billion yuan distributed over the past three years [2]. Stock Performance - As of September 19, WuXi AppTec's stock price was 105.22 yuan per share, with a market capitalization of 310.558 billion yuan. The stock has increased by 95.90% year-to-date, with a slight decline of 0.24% over the past five trading days [1]. - The trading volume on September 19 was 3.397 billion yuan, with a turnover rate of 1.28% [1]. Shareholder Structure - As of June 30, 2025, the second-largest shareholder is Hong Kong Central Clearing Limited, holding 302 million shares, an increase of 56.0239 million shares from the previous period. Other notable shareholders include Huaxia SSE 50 ETF and China Europe Medical Health Mixed A [3]. Industry Classification - WuXi AppTec is classified under the pharmaceutical and biotechnology sector, specifically in medical services and contract research organization (CRO) services. The company is associated with concepts such as cell therapy, precision medicine, innovative drugs, and overseas expansion [2].

Group 1 - The core transaction of WuXi AppTec occurred on September 18, with a volume of 50,000 shares and a transaction amount of 5.3715 million yuan, at a price of 107.43 yuan per share [2] - In the last three months, WuXi AppTec has had a total of four block trades, amounting to 38.301 million yuan [3] - The closing price of WuXi AppTec on the same day was 107.43 yuan, reflecting a decrease of 1.70%, with a turnover rate of 2.20% and a total trading volume of 5.895 billion yuan [3] Group 2 - The latest margin financing balance for WuXi AppTec is 5.966 billion yuan, which has decreased by 162 million yuan over the past five days, representing a decline of 2.65% [4] - The net outflow of main funds for WuXi AppTec on that day was 207 million yuan, while the stock has seen a cumulative increase of 2.66% over the past five days, with a total net inflow of 32.3834 million yuan [3]

Group 1 - WuXi AppTec's stock closed down 1.70% on September 18, with a closing price of 107.43 yuan [1] - A block trade occurred with a total volume of 50,000 shares and a transaction amount of 5.3715 million yuan, with a premium rate of 0.00% [1] - The buyer was Huatai Securities Co., Ltd., and the seller was Guotai Junan Securities Co., Ltd. [1] Group 2 - In the last three months, WuXi AppTec has had a total of four block trades, with a cumulative transaction amount of 38.301 million yuan [1] - Over the past five trading days, the stock has increased by 2.66%, with a net inflow of main funds totaling 12.6333 million yuan [1]